Caris Life Sciences (CAI) Treasury Shares (2024 - 2026)

Caris Life Sciences' Treasury Shares history runs 3 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• On a quarterly basis, Treasury Shares changed N/A year-over-year to $16.9 million in Q1 2026; TTM through Mar 2026 was $16.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $16.9 million, up 5020.0% from the prior year.
• Treasury Shares held at $16.9 million in Q1 2026 per CAI's latest filing, from $16.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $734.1 million in Q2 2024 and bottomed at $1.6 million in Q2 2025.
• The 3-year median for Treasury Shares is $371.7 million (2024), against an average of $369.5 million.
• Biggest YoY gain for Treasury Shares was 5020.0% in 2025; the steepest drop was 5020.0% in 2025.
• Year by year, Treasury Shares stood at $330000.0 in 2024, then surged by 5020.0% to $16.9 million in 2025, then changed by 0.0% to $16.9 million in 2026.
• Per Business Quant, the three latest CAI Treasury Shares figures stand at $16.9 million (Q1 2026), $16.9 million (Q4 2025), and $16.9 million (Q3 2025).